Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis

Free Radic Biol Med. 2009 Mar 1;46(5):555-63. doi: 10.1016/j.freeradbiomed.2008.10.051. Epub 2008 Nov 17.

Abstract

Repetitive stress has been shown to up-regulate antioxidant defense and increase survival after subsequent oxidative injury. The up-regulation of antioxidant defense has been identified as an underlying cause of the apoptosis-inhibitory effects exerted by repetitive stress. However, it remains unclear what the important signaling mechanisms are by which cells preexposed to low-grade stress deal with apoptosis-inducing stress. In this study, we repetitively stressed human umbilical vein endothelial cells (HUVECs) through multiple exposures to a low dose (30 microM) of H(2)O(2) in culture for 4 weeks. We then examined the effects of repetitive stress on PPAR-beta expression and activity as well as the role of PPAR-beta in the protective potency of repetitive stress. Our results show that repetitive stress enhances PPAR-beta expression and activity, thereby inhibiting oxidative stress-induced apoptosis. Further, PPAR-beta-directed antisense oligonucleotides reduced the PPAR-beta protein content, enhanced the H(2)O(2)-mediated apoptosis, and ablated the protective effect of repetitive low-grade H(2)O(2) stress. The specific PPAR-beta agonist L-165041 significantly potentiated the apoptosis induced by H(2)O(2) (p<0.05) and increased the protective effect of repetitive stress. These findings indicate that repetitive low-grade H(2)O(2) stress protects HUVECs from subsequent oxidative stress-induced apoptosis by enhancing PPAR-beta expression and activity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / physiology
  • Cell Line
  • Endothelial Cells / pathology
  • Endothelial Cells / physiology*
  • Humans
  • Hydrogen Peroxide / pharmacology*
  • Imidazoles / pharmacology
  • NF-kappa B / antagonists & inhibitors
  • Oligonucleotides, Antisense / genetics
  • Oxidative Stress / drug effects*
  • Oxidative Stress / physiology
  • PPAR-beta / agonists
  • PPAR-beta / antagonists & inhibitors
  • PPAR-beta / genetics
  • PPAR-beta / metabolism*
  • Peptides / pharmacology
  • Phenoxyacetates / pharmacology
  • Pyridines / pharmacology
  • Signal Transduction / physiology
  • Stress, Physiological / physiology
  • Transcriptional Activation
  • Umbilical Veins / pathology
  • Umbilical Veins / physiology*
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors

Substances

  • 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid
  • Imidazoles
  • NF-kappa B
  • Oligonucleotides, Antisense
  • PPAR-beta
  • Peptides
  • Phenoxyacetates
  • Pyridines
  • SN50 peptide
  • Hydrogen Peroxide
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580